Since September 2025, the Trump administration has conducted an undeclared war in the Caribbean Sea and Pacific Ocean, killing scores of civilians by deploying drone strikes on boats they allege are ...

After Pentagon press secretary Kingsley Wilson declared the War Department was certain about the identities of supposed drug smugglers killed in boat strikes, Rep. Chrissy Houlahan, D-Pa., had some ...

During the week of October 25 through November 1, for the first time in 35 years, no rap songs appeared on Billboard’s top 40. For many, it signaled the death knell of hip-hop’s slow, but imminent, ...

The grocery store formerly known as Steve’s 9th Street Supermarket in Park Slope has a new occupant. K Slope Market, a full-service supermarket and member of the Key Food Cooperative, opened its doors ...

The song has been streamed over 3 million times in under a month. A song created through artificial intelligence has made history topping a Billboard country music chart, but it has also sent ...

This content was first published in Golf Journal, a quarterly print and monthly digital publication exclusively for USGA Members. To be among the first to receive Golf Journal and to learn how you can ...

U.S. fighter jets scrambled Wednesday to intercept four Russian warplanes off the coast of Alaska, the North American Aerospace Defense Command (NORAD) said Thursday. NORAD said in a statement it ...

U.S. fighter jets were scrambled Wednesday to identify and intercept four Russian warplanes flying near Alaska, the North American Aerospace Defense Command said in a statement. NORAD said two Russian ...

While the path for any drug to go from lab research to commercialization takes years, Intercept Pharmaceuticals now stands as another example that a product’s market exit can also be long and winding.

Please provide your email address to receive an email when new articles are posted on . Intercept has voluntarily withdrawn its lone product, Ocaliva, from U.S. market for primary biliary cholangitis.

Sept 11 (Reuters) - Intercept Pharmaceuticals said on Thursday it is withdrawing its liver disease drug from the U.S. market following a request from the Food and Drug Administration. This comes as ...